Biomedical Biotechnology
This track explores the application of biotechnology in developing diagnostic tools, therapeutics, and medical devices. Emphasis will be on emerging technologies like nanobiotechnology and tissue engineering.
Topics:
- Nanobiotechnology in Medicine
- Bioprinting and Regenerative Medicine
- Advances in Biomarkers and Diagnostics
- Drug Delivery Systems
Related Conference of Biomedical Biotechnology
June 29-30, 2026
41st International Conference on Next-Gen Biotechnology and Applications
Aix-en-Provence, France
August 13-14, 2026
21st World Congress on Biomarkers, Cancer Therapy & Clinical Research
San Diego, USA
Biomedical Biotechnology Conference Speakers
Recommended Sessions
- Advances in Genomic Biotechnology
- Biomedical Biotechnology
- Biopharmaceuticals and Biosimilars
- Biotechnology and Global Health
- Biotechnology in Agriculture
- Computational and Systems Biology
- Environmental Biotechnology
- Future Trends in Biotechnology
- Industrial Biotechnology
- Industrial Scale-Up and Bioprocessing
- Marine Biotechnology
- Microbial Biotechnology
- Stem Cell and Regenerative Medicine
- Synthetic Biology and Bioengineering
- Vaccine Development and Immunotherapy
Related Journals
Are you interested in
- Advancements in Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Agricultural Biotechnology & Crop Improvement - Biotechnology- 2026 (Germany)
- Analytical Challenges in Personalized Medicine - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in Agriculture - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in the Energy Sector - ANALYTICA ACTA 2026 (France)
- Analytical Techniques and Laboratory Methods - BIOMEDICINE 2026 (Italy)
- Analytical Techniques for Biotechnology - ANALYTICA ACTA 2026 (France)
- Analytical Techniques in Material Science - ANALYTICA ACTA 2026 (France)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Artificial Intelligence in Drug Discovery and Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Automation in Bioanalytical Laboratories - ANALYTICA ACTA 2026 (France)
- Bioanalytical Method Development and Validation - ANALYTICA ACTA 2026 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioinformatics & Computational Biology - Biotechnology- 2026 (Germany)
- Bioinformatics and Biomarkers - Biomarkers 2026 (USA)
- Bioinformatics and Computational Approaches - ANALYTICA ACTA 2026 (France)
- Biomarker Detection Technologies - Biomarkers 2026 (USA)
- Biomarkers in Drug Development - Biomarkers 2026 (USA)
- Biopharmaceutical Development - Biotechnology- 2026 (Germany)
- Biopharmaceuticals and Biologics - ANALYTICA ACTA 2026 (France)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Chemical Analysis and Sensing - ANALYTICA ACTA 2026 (France)
- Clinical and Forensic Analysis - ANALYTICA ACTA 2026 (France)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2026 (Italy)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Clinical Trials and Translational Research - BIOMEDICINE 2026 (Italy)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- CRISPR & Gene Therapy Applications - Biotechnology- 2026 (Germany)
- Data Integrity and Compliance in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Drug Discovery and Development - BIOMEDICINE 2026 (Italy)
- Emerging Contaminants and Analytical Challenges - ANALYTICA ACTA 2026 (France)
- Emerging Therapies and Innovative Drugs - BIOMEDICINE 2026 (Italy)
- Emerging Trends in Analytical and Bioanalytical Techniques - ANALYTICA ACTA 2026 (France)
- Environmental & Green Biotechnology - Biotechnology- 2026 (Germany)
- Environmental Analysis - ANALYTICA ACTA 2026 (France)
- Environmental Biomarkers - Biomarkers 2026 (USA)
- Epigenetic Biomarkers - Biomarkers 2026 (USA)
- Ethics in Biomarker Research - Biomarkers 2026 (USA)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Food and Beverage Analysis - ANALYTICA ACTA 2026 (France)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biomarker Research - Biomarkers 2026 (USA)
- Genetic Engineering & Genome Editing - Biotechnology- 2026 (Germany)
- Genomic Biomarkers - Biomarkers 2026 (USA)
- Genomics and Molecular Biology Analysis - ANALYTICA ACTA 2026 (France)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- High-Resolution Techniques - ANALYTICA ACTA 2026 (France)
- Imaging Techniques and Microscopy - ANALYTICA ACTA 2026 (France)
- Immunobiology and Immunotherapy in Biomedicine - BIOMEDICINE 2026 (Italy)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Immunotherapy and Biologics - BIOMEDICINE 2026 (Italy)
- Industrial Biotechnology & Bioprocessing - Biotechnology- 2026 (Germany)
- Infectious Disease Biomarkers - Biomarkers 2026 (USA)
- Instrumentation and Automation in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Liquid Biopsies in Oncology - Biomarkers 2026 (USA)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Metabolomics and Proteomics - ANALYTICA ACTA 2026 (France)
- Microbial Biotechnology & Fermentation - Biotechnology- 2026 (Germany)
- Molecular Diagnostics & Biomarkers - Biotechnology- 2026 (Germany)
- Molecular Diagnostics and Biomarker Discovery - BIOMEDICINE 2026 (Italy)
- Molecular Medicine and Genetics - BIOMEDICINE 2026 (Italy)
- Monitoring Chronic Disease with Biomarkers - Biomarkers 2026 (USA)
- Nanobiotechnology & Drug Delivery - Biotechnology- 2026 (Germany)
- Nanobiotechnology in Biomedicine - BIOMEDICINE 2026 (Italy)
- Nanomaterials and Nanotechnology in Analysis - ANALYTICA ACTA 2026 (France)
- Nanomedicine and Drug Delivery Systems - BIOMEDICINE 2026 (Italy)
- Nanotechnology Applications in Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Natural Products and Phytopharmacology - BIOMEDICINE 2026 (Italy)
- Neuropharmacology and Central Nervous System Therapies - BIOMEDICINE 2026 (Italy)
- Oncology Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Pediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Pediatric Biomarkers - Biomarkers 2026 (USA)
- Personalized & Precision Medicine - Biotechnology- 2026 (Germany)
- Pharmaceutical Analysis - ANALYTICA ACTA 2026 (France)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2026 (Italy)
- Pharmacovigilance and Drug Regulation - BIOMEDICINE 2026 (Italy)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Proteomics in Biomarker Discovery - Biomarkers 2026 (USA)
- Psychiatric Biomarkers - Biomarkers 2026 (USA)
- Quality by Design (QbD) in Analytical Method Development - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Cell Therapy - BIOMEDICINE 2026 (Italy)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Spectroscopic Techniques - ANALYTICA ACTA 2026 (France)
- Stem Cell Innovations - Biotechnology- 2026 (Germany)
- Stem Cell Therapy and Regenerative Biomedicine - BIOMEDICINE 2026 (Italy)
- Surface and Interface Analysis - ANALYTICA ACTA 2026 (France)
- Synthetic & Systems Biology - Biotechnology- 2026 (Germany)
- Systems Pharmacology and Computational Biology - BIOMEDICINE 2026 (Italy)
- Tissue Engineering & Regenerative Medicine - Biotechnology- 2026 (Germany)
- Toxicology and Safety Assessment - BIOMEDICINE 2026 (Italy)
- Translational Biomarker Research - Biomarkers 2026 (USA)
- Translational Biotechnology & Commercialization - Biotechnology- 2026 (Germany)
- Workshops and Hands-On Training - ANALYTICA ACTA 2026 (France)